- Home
- IMUX vs NHTC Comparison
IMUX vs NHTC Comparison
Compare IMUX & NHTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- NHTC
- Stock Information
- Founded
- IMUX 2016
- NHTC 1988
- Country
- IMUX United States
- NHTC United States
- Employees
- IMUX N/A
- NHTC N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- NHTC Diversified Commercial Services
- Sector
- IMUX Health Care
- NHTC Miscellaneous
- Exchange
- IMUX Nasdaq
- NHTC Nasdaq
- Market Cap
- IMUX 67.8M
- NHTC 55.8M
- IPO Year
- IMUX N/A
- NHTC 1995
- Fundamental
- Price
- IMUX $0.70
- NHTC $4.45
- Analyst Decision
- IMUX Strong Buy
- NHTC
- Analyst Count
- IMUX 6
- NHTC 0
- Target Price
- IMUX $11.60
- NHTC N/A
- AVG Volume (30 Days)
- IMUX 2.6M
- NHTC 17.4K
- Earning Date
- IMUX 08-07-2025
- NHTC 07-30-2025
- Dividend Yield
- IMUX N/A
- NHTC 17.99%
- EPS Growth
- IMUX N/A
- NHTC N/A
- EPS
- IMUX N/A
- NHTC 0.04
- Revenue
- IMUX N/A
- NHTC $42,749,000.00
- Revenue This Year
- IMUX N/A
- NHTC N/A
- Revenue Next Year
- IMUX N/A
- NHTC N/A
- P/E Ratio
- IMUX N/A
- NHTC $108.21
- Revenue Growth
- IMUX N/A
- NHTC N/A
- 52 Week Low
- IMUX $0.56
- NHTC $4.02
- 52 Week High
- IMUX $2.11
- NHTC $7.35
- Technical
- Relative Strength Index (RSI)
- IMUX 35.71
- NHTC 41.46
- Support Level
- IMUX $0.68
- NHTC $4.27
- Resistance Level
- IMUX $0.75
- NHTC $4.47
- Average True Range (ATR)
- IMUX 0.06
- NHTC 0.14
- MACD
- IMUX -0.00
- NHTC -0.01
- Stochastic Oscillator
- IMUX 10.40
- NHTC 32.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.